We use first-party cookies to provide you the best possible experience. Necessary. By clicking "Accept", you agree to the use of our cookies on your device. By clicking "Decline", you can continue browsing but certain features may be limited.

World'sLargestAI-Powered
TherapeuticAssetAccelerator

Partex.AI is solving the inefficiency problem in Drug Discovery & Development using Big Data & Artificial Intelligence

Opportunity

Over 18,000 drugs in clinical development globally, with 8,000 in the U.S. - only ~50 drugs approved by FDA per year

In-licensing or out-licensing takes over 3 years, consuming more than 25% of the drug’s patent life

$1.3Tn global pharma market, growing at 6% CAGR is facing a $300Bn patent cliff, with 6 of the top 10 oncology drugs losing exclusivity within the next 4 years

"Unlocking a $50Bn opportunity for AI in drug discovery and development"

What We Do

With unrivalled computing power, an AI-first approach, a multi-disciplinary team, and holistic datasets, Partex.AI empowers the life science industry to develop drugs faster, more cost effective, and more targeted. Validated by wet-lab and Real-World Data, AI at scale unlocks the hidden value in already discovered therapeutic assets

Therapeutics

Identifying late stage preclinical - early clinical drug assets with strong scientific foundations but suboptimal development paths, Partex.AI’s proprietary models optimize therapeutics towards their key value inflection. Partex.AI is currently incubating three promising drug assets in oncology within focused SPVs

Exchange

Pharma and biotech partner with Partex.AI to unlock value from deprioritized or off-strategy drug assets through AI-driven in- and out-licensing. By data-enabling asset evaluation and repositioning, we facilitate and accelerate efficient pipeline optimization through adaptable, value-based collaboration models

Labs

Driving the future of AI-powered drug discovery, we specialize in developing next-generation functional assays and high-throughput experimental screening to rigorously test and confirm AI-driven predictions. By integrating advanced computational modeling with hands-on laboratory science in disease-relevant systems, we create a seamless, closed-loop model - delivering tangible, experimental evidence supporting our AI hypotheses

Real-World Data

Driving innovation and transforming healthcare through equitable and trustworthy Real-World Data, Partex.AI is building scalable global partnerships with healthcare providers to leverage RWD for drug development and treatment optimization, ultimately improving patient’s outcomes

How We Do It

We don't just discover drugs,

we manage their future

Talk to us to explore licensing, partnerships, or how AI can reshape your drug pipeline

World'sLargestAI-PoweredTherapeuticAssetAccelerator